Suscribete

Improving Endpoints for Cancer Immunotherapy Clinical Trials

The Cancer Research Institute Cancer Immunotherapy Consortium, the leading global initiative in advancing the emerging field of...

2010 William B. Coley Award Winners to be Honored at CRI’s 24th Annual Awards Dinner in NYC

CRI announced today the three winners of the 2010 William B. Coley Award for Distinguished Research in...

New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer

A significant new immunotherapy, created by CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D, is...

First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy

CRI celebrates yesterday’s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food...

Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response

A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool...

2010 Grace Award Winners Announced

CRI announced today that it will present fashion designer Michael Kors and GlaxoSmithKline CEO Andrew Witty with...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.